NEW YORK (GenomeWeb News) – In Nature Genetics, two teams described the immune region-focused, Immunochip array-based strategy that they used to find sites in the genome with ties to a serious liver disease called primary sclerosing cholangitis and to a form of childhood rheumatoid arthritis called juvenile idiopathic arthritis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.